Showing all 4 results
Lamivudine Tablets
FreeProduct Composition & Available Portfolio strengths
We manufacture Lamivudine across the precise compendial strengths mandated to manage either targeted chronic hepatic monotherapy or high-potency systemic combination antiretroviral protocols.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lamivudine USP / BP / IP 100 mg Oral Solid Film-Coated Tablet Chronic Hepatitis B (HBV): Low-dose configuration optimized for standalone daily suppression of active hepatic viral replication. Lamivudine USP / BP / IP 150 mg Oral Solid Film-Coated Tablet Standard Antiretroviral (HIV): Baseline strength designed for twice-daily co-administration or integration into standard multi-drug ARV regimens. Lamivudine USP / BP / IP 300 mg Oral High-Potency Solid Tablet High-Compliance Antiretroviral (HIV): Standard adult once-daily high-dose format engineered to optimize long-term patient compliance. Nelfinavir Tablet
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. Due to the high dose required for therapeutic efficacy, we ensure the tablet is engineered for ease of swallowing without compromising the structural integrity of the high-API load.
Active Ingredient Strength (Standard) Therapeutic Role Nelfinavir Mesylate USP/BP 250 mg Standard Adult / Pediatric Dose Nelfinavir Mesylate USP/BP 625 mg High-Strength Adult Maintenance Excipients Q.S. Calcium Silicate / Crospovidone Disintegrant & Stabilizer Tenofovir Tablets
FreeAbivir
Tenofovir Disoproxil Fumarate Tablet 300 mg
Each Film Coated Tablet Contains:
Tenofovir Disoproxil Fumarate 300 mgUsage: – help control HIV infection
Category: – HIV Anti viral drugs
Therapeutic category: – Antiviral, Anti HIV
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Zidovudine Tablet
FreeProduct Composition & Strength
We supply this product in standardized strengths optimized for both monotherapy (in specific PMTCT cases) and combination therapy (HAART).
Active Ingredient Strength Primary Clinical Target Zidovudine IP/BP/USP 300 mg The Foundation: Standard dose for adult HIV management. Excipients Pharma Grade The Matrix: Ensures shelf-life stability and rapid absorption.
